XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -6.68%285.82M | -10.35%70.97M | -2.44%102.3M | -17.33%39.69M | -1.87%72.86M | 59.26%306.28M | 78.02%79.17M | 50.65%104.86M | 161.92%48.01M | 23.94%74.24M |
Net income from continuing operations | 33.96%132.85M | 54.05%42.22M | -33.97%38.44M | 158.24%38.04M | 1,301.53%14.15M | 172.85%99.17M | 36.04%27.41M | 539.17%58.22M | 83.91%14.73M | -28.74%-1.18M |
Depreciation and amortization | -21.02%55.5M | -1.56%15.3M | -26.02%13.03M | -27.31%13.39M | -26.27%13.79M | -9.52%70.27M | -16.16%15.54M | -9.73%17.61M | -34.53%18.42M | 62.79%18.7M |
Deferred tax | -12.51%-24.92M | 43.54%-7.51M | -145.94%-15.3M | 99.40%-133K | 90.05%-1.98M | 60.88%-22.15M | 13.93%-13.31M | 295.35%33.3M | -70.90%-22.29M | -79.36%-19.86M |
Other non cash items | -5.01%22.44M | 8.60%6.56M | 10.51%6.56M | -43.54%3.01M | -0.03%6.31M | 18.94%23.63M | 18.47%6.04M | 5.30%5.94M | 247.87%5.34M | -50.44%6.31M |
Change In working capital | -7.26%-109.78M | -0.61%-30.89M | 104.61%3.03M | -247.28%-68.14M | -200.81%-13.78M | -33.79%-102.35M | -13.97%-30.7M | -2,791.81%-65.7M | 57.65%-19.62M | 1,523.96%13.67M |
-Change in receivables | 7.12%-51.03M | -1,156.88%-6.94M | 37.94%-12.42M | 3.19%-18.5M | 13.74%-13.18M | -10.88%-54.95M | 95.17%-552K | -146.50%-20.01M | -5.87%-19.11M | -27.70%-15.28M |
-Change in prepaid assets | -374.60%-24.31M | -21.74%-10.01M | 106.76%612K | -15.26%-9.86M | -124.41%-5.06M | 85.78%-5.12M | -311.52%-8.22M | 49.05%-9.06M | 41.64%-8.55M | 376.34%20.71M |
-Change in payables and accrued expense | 288.30%4.8M | 67.53%-4.04M | 190.50%24.73M | -261.78%-30.07M | -23.98%14.17M | -105.18%-2.55M | -34.23%-12.44M | -181.02%-27.33M | 661.28%18.58M | -33.41%18.64M |
-Change in other current liabilities | 1.27%-39.23M | -4.41%-9.9M | -6.30%-9.9M | 7.82%-9.72M | 6.58%-9.71M | 0.81%-39.73M | 6.42%-9.48M | 7.94%-9.31M | -2.18%-10.55M | -9.53%-10.4M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -6.68%285.82M | -10.35%70.97M | -2.44%102.3M | -17.33%39.69M | -1.87%72.86M | 59.26%306.28M | 78.02%79.17M | 50.65%104.86M | 161.92%48.01M | 23.94%74.24M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -41.30%-77.27M | -421.06%-42.83M | -2,812.86%-11.39M | -73.28%-16.64M | 82.83%-6.4M | 56.65%-54.68M | 44.60%-8.22M | 100.43%420K | -21.52%-9.61M | -467.00%-37.28M |
Net PPE purchase and sale | -39.11%-37.35M | -83.59%-11.01M | -71.37%-9.76M | -25.57%-9.59M | 7.06%-6.99M | 16.05%-26.85M | 49.50%-6M | -1.62%-5.7M | 2.89%-7.64M | -13.29%-7.52M |
Net business purchase and sale | ---66.2M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Net investment purchase and sale | 193.79%26.29M | 1,635.71%34.66M | -127.28%-1.67M | -245.95%-7.18M | 101.60%476K | 70.26%-28.03M | 25.09%-2.26M | 106.69%6.1M | ---2.08M | ---29.8M |
Net other investing changes | -105.13%-10K | -894.29%-278K | 142.86%34K | 17.92%125K | 172.50%109K | 107.45%195K | -31.37%35K | -41.67%14K | 352.38%106K | -34.43%40K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -41.30%-77.27M | -421.06%-42.83M | -2,812.86%-11.39M | -73.28%-16.64M | 82.83%-6.4M | 56.65%-54.68M | 44.60%-8.22M | 100.43%420K | -21.52%-9.61M | -467.00%-37.28M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -23.11%-303.8M | -11.41%-70.8M | -17.45%-82.6M | -14.40%-66.58M | -53.24%-83.83M | -3.89%-246.78M | -14.48%-63.55M | -15.29%-70.33M | -9.66%-58.2M | 19.49%-54.71M |
Net common stock issuance | -25.59%-251.18M | -25.56%-62.78M | -31.49%-65.74M | -20.31%-60.16M | -25.00%-62.5M | 0.00%-200M | 0.00%-50M | 0.00%-50M | -0.00%-50M | 0.01%-50M |
Proceeds from stock option exercised by employees | -47.38%20.79M | -30.31%7.35M | --0 | 12.58%12.89M | -96.26%548K | 68.15%39.51M | 43.49%10.55M | -44.05%2.86M | 9.17%11.45M | 2,612.41%14.65M |
Net other financing activities | 14.92%-73.41M | 36.23%-15.37M | 27.33%-16.85M | 1.72%-19.31M | -13.06%-21.88M | -41.40%-86.29M | -87.36%-24.1M | -43.91%-23.19M | -44.89%-19.65M | -4.69%-19.35M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -23.11%-303.8M | -11.41%-70.8M | -17.45%-82.6M | -14.40%-66.58M | -53.24%-83.83M | -3.89%-246.78M | -14.48%-63.55M | -15.29%-70.33M | -9.66%-58.2M | 19.49%-54.71M |
Net cash flow | ||||||||||
Beginning cash position | 2.23%314M | -14.23%261.98M | -6.64%252.79M | 2.17%296.14M | 2.23%314M | -36.10%307.14M | -8.03%305.45M | -35.87%270.77M | -37.79%289.84M | -36.10%307.14M |
Current changes in cash | -2,077.02%-95.25M | -675.94%-42.65M | -76.23%8.31M | -119.89%-43.53M | 2.03%-17.38M | 102.81%4.82M | 128.62%7.41M | 139.62%34.95M | 53.58%-19.8M | -21.31%-17.74M |
Effect of exchange rate changes | -152.15%-1.07M | -244.09%-1.65M | 421.69%875K | -74.18%190K | -210.48%-485K | 195.79%2.05M | 27.85%1.14M | 85.50%-272K | 169.90%736K | 534.65%439K |
End cash Position | -30.67%217.68M | -30.67%217.68M | -14.23%261.98M | -6.64%252.79M | 2.17%296.14M | 2.23%314M | 2.23%314M | -8.03%305.45M | -35.87%270.77M | -37.79%289.84M |
Free cash flow | -11.08%248.47M | -18.05%59.96M | -6.68%92.54M | -25.44%30.1M | -1.29%65.87M | 74.29%279.43M | 124.47%73.17M | 54.95%99.16M | 285.71%40.37M | 25.27%66.73M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |